Post-Operative Prediction of PulmonarY Function

ConditionLung Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Sydney

About this trial

Prediction of postoperative lung function is currently based on anatomical segment counting (ASC), which incorporates pulmonary function test (PFT) results. Standard PFTs such as spirometry can only measure pulmonary capacity as an average over the entire lung and do not take regional function differences into account. Nuclear medicine is recommended where regional functional imaging is required to inform surgical decisions. However, nuclear medicine scans are expensive, time consuming and not available in all institutions. CT-ventilation imaging is a cheaper and more accessible alternative to nuclear medicine for informing lung cancer patient treatment choices.

The primary aim is to quantify the difference between predicted postoperative values of pulmonary function metrics derived from CT ventilation imaging and standard anatomical segment counting method.

Eligibility criteria

Qualifiers

Aged 18 years or older.

ECOG performance status 0-2.

Lung cancer surgical candidates.

Undergo SPECT V/Q scans within 8 weeks of registration.

Disqualifiers

Interstitial lung disease.

Pregnant women.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Royal North Shore HospitalRecruiting2065, Saint Leonards, New South WalesAustraliaAustralia

Sponsors and collaborators

University of Sydney

Lead sponsor

Royal North Shore Hospital

Collaborator